We invite those 18 to 85 years old who are experiencing involuntary movements in their face or other parts of their body – and suffer from schizophrenia or schizoaffective disorder – to see if they may qualify for the Kinect Study. The purpose of this clinical research study is to determine the safety and effectiveness of an investigational oral medication for tardive dyskinesia.
Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive study medication, study-related medical exams, and lab tests at no charge. To learn more, visit our website www.KinectStudy.com
NeuroTrials Research, Inc.
1100 Johnson Ferry Road
Atlanta, GA 30342
Contact: Katy McNulty at 404-851-9934
The Mood and Anxiety Disorders Program of Emory University School of Medicine is dedicated to researching health care on a global level and treating it on a personal level. The purpose of their program is to help find improved treatments for depression and anxiety disorders. Most of Emory’s studies involve the evaluation of a medication while others may involve psychotherapy or other non-medication treatments. Their staff includes an experienced team of medical doctors, psychologists, social workers and nurses in the field of psychiatry and medical research. Emory offers clinical trials at no cost to individuals who participate in their research studies. All research is done at their office which is located on the Emory University campus in Atlanta, GA. Participation in Emory’s program is confidential. If you have any questions, please call 404-778-MOOD (6663).